{"protocolSection": {"identificationModule": {"nctId": "NCT00722371", "orgStudyIdInfo": {"id": "0431-102"}, "secondaryIdInfos": [{"id": "2008_522", "type": "OTHER", "domain": "Merck Study Number"}], "organization": {"fullName": "Merck Sharp & Dohme LLC", "class": "INDUSTRY"}, "briefTitle": "MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)", "officialTitle": "A Multicenter, Randomized, Double-Blind Study of the Co-Administration of Sitagliptin and Pioglitazone in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control"}, "statusModule": {"statusVerifiedDate": "2017-04", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2008-09-05", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2010-10-26", "type": "ACTUAL"}, "completionDateStruct": {"date": "2011-03-25", "type": "ACTUAL"}, "studyFirstSubmitDate": "2008-07-22", "studyFirstSubmitQcDate": "2008-07-24", "studyFirstPostDateStruct": {"date": "2008-07-25", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2011-09-09", "resultsFirstSubmitQcDate": "2011-09-09", "resultsFirstPostDateStruct": {"date": "2011-10-17", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2017-04-07", "lastUpdatePostDateStruct": {"date": "2017-05-12", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Merck Sharp & Dohme LLC", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "A study to evaluate the efficacy and safety of sitagliptin and pioglitazone co-administration in comparison with sitagliptin and pioglitazone monotherapy in patients with type 2 diabetes."}, "conditionsModule": {"conditions": ["Type 2 Diabetes Mellitus"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 1615, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Sitagliptin 100 mg", "type": "EXPERIMENTAL", "interventionNames": ["Drug: Sitagliptin phosphate", "Drug: Matching placebo to pioglitazone", "Drug: Metformin"]}, {"label": "Pioglitazone 15 mg", "type": "EXPERIMENTAL", "interventionNames": ["Drug: Pioglitazone hydrochloride", "Drug: Matching placebo to sitagliptin", "Drug: Metformin"]}, {"label": "Pioglitazone 30 mg", "type": "EXPERIMENTAL", "interventionNames": ["Drug: Pioglitazone hydrochloride", "Drug: Matching placebo to sitagliptin", "Drug: Metformin"]}, {"label": "Pioglitazone 45 mg", "type": "EXPERIMENTAL", "interventionNames": ["Drug: Pioglitazone hydrochloride", "Drug: Matching placebo to sitagliptin", "Drug: Metformin"]}, {"label": "Sitagliptin 100 mg/ Pioglitazone 15 mg", "type": "EXPERIMENTAL", "interventionNames": ["Drug: Sitagliptin phosphate", "Drug: Pioglitazone hydrochloride", "Drug: Metformin"]}, {"label": "Sitagliptin 100 mg/ Pioglitazone 30 mg", "type": "EXPERIMENTAL", "interventionNames": ["Drug: Sitagliptin phosphate", "Drug: Pioglitazone hydrochloride", "Drug: Metformin"]}, {"label": "Sitagliptin 100 mg/ Pioglitazone 45 mg", "type": "EXPERIMENTAL", "interventionNames": ["Drug: Sitagliptin phosphate", "Drug: Pioglitazone hydrochloride", "Drug: Metformin"]}], "interventions": [{"type": "DRUG", "name": "Sitagliptin phosphate", "description": "Sitagliptin 100 mg tablet (blinded) orally once daily for 54 weeks.", "armGroupLabels": ["Sitagliptin 100 mg", "Sitagliptin 100 mg/ Pioglitazone 15 mg", "Sitagliptin 100 mg/ Pioglitazone 30 mg", "Sitagliptin 100 mg/ Pioglitazone 45 mg"], "otherNames": ["Januvia", "Tesavel", "Xelevia", "Ristaben"]}, {"type": "DRUG", "name": "Pioglitazone hydrochloride", "description": "Pioglitazone 15 mg, 30 mg, or 45 mg tablets or capsules (blinded) orally once daily for 54 weeks. Participants randomized to receive pioglitazone 45 mg as monotherapy or in combination with sitagliptin were to start on pioglitazone 30 mg at Week 1 and undergo uptitration to pioglitazone 45 mg at Week 4.", "armGroupLabels": ["Pioglitazone 15 mg", "Pioglitazone 30 mg", "Pioglitazone 45 mg", "Sitagliptin 100 mg/ Pioglitazone 15 mg", "Sitagliptin 100 mg/ Pioglitazone 30 mg", "Sitagliptin 100 mg/ Pioglitazone 45 mg"], "otherNames": ["Actos"]}, {"type": "DRUG", "name": "Matching placebo to sitagliptin", "description": "Matching placebo to sitagliptin orally once daily for 54 weeks.", "armGroupLabels": ["Pioglitazone 15 mg", "Pioglitazone 30 mg", "Pioglitazone 45 mg"]}, {"type": "DRUG", "name": "Matching placebo to pioglitazone", "description": "Matching placebo to pioglitazone tablets or capsules orally once daily for 54 weeks.", "armGroupLabels": ["Sitagliptin 100 mg"]}, {"type": "DRUG", "name": "Metformin", "description": "Metformin 500 mg (open-label) was to be initiated as rescue therapy to participants not meeting specific glycemic goals. The dose of metformin may have been uptitrated and adjusted, at the discretion of the investigator, up to the maximum approved dose in the country of origin.", "armGroupLabels": ["Pioglitazone 15 mg", "Pioglitazone 30 mg", "Pioglitazone 45 mg", "Sitagliptin 100 mg", "Sitagliptin 100 mg/ Pioglitazone 15 mg", "Sitagliptin 100 mg/ Pioglitazone 30 mg", "Sitagliptin 100 mg/ Pioglitazone 45 mg"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Change From Baseline in Hemoglobin A1C (A1C) at Week 24", "description": "A1C represents the percentage of glycosylated hemoglobin.", "timeFrame": "Baseline and Week 24"}, {"measure": "Change From Baseline in A1C at Week 54", "description": "A1C represents the percentage of glycosylated hemoglobin.", "timeFrame": "Baseline and Week 54"}], "secondaryOutcomes": [{"measure": "Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24", "timeFrame": "Baseline and Week 24"}, {"measure": "Change From Baseline in 2-Hour Post-meal Glucose (PMG) at Week 24", "description": "PMG was measured using the Meal Tolerance Test (MTT).", "timeFrame": "Baseline and Week 24"}, {"measure": "Change From Baseline in FPG at Week 54", "timeFrame": "Baseline and Week 54"}, {"measure": "Change From Baseline in 2-Hour PMG at Week 54", "description": "PMG was measured using the Meal Tolerance Test (MTT).", "timeFrame": "Baseline and Week 54"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patient is highly unlikely to conceive\n* Patient meets one of the 3 categories is na\u00efve to all antihyperglycemic agent (AHA) therapies, or is non-na\u00efve based upon the patient's current diet, medical regimen and screening A1c patient is currently not on AHA with a screening A1c \\>=7.5 % and =\\<11.0 % patient is currently on either metformin pr sulfonylurea monotherapy with a screening A1c \\>=7.0 % and =\\<9.0 %\n\nExclusion Criteria\n\n* Patient has a history of type 1 diabetes mellitus or history of ketoacidosis or has C=peptide value of =\\<0.8 ng/mL\n* Patient has previously been treated with insulin, thiazolidinedione (TZD) (rosiglitazone or pioglitazone), any Dipeptidyl peptidase-4 (DPP-4) inhibitor (sitagliptin, vildagliptin, or alogliptin), exenatide or has previously been in a clinical study with any DPP-4 inhibitor or incretin mimetic\n* Patient is on a weight loss program and is not in the maintenance phase or has started a weight loss medication (e.g. orlistat or sibutramine) within the prior 8 weeks\n* Patient has undergone surgery within the prior 30 days or has major surgery planned during the study\n* Patient has a medical history of active liver disease including chronic active hepatitis B or C or symptomatic gallbladder disease including primary biliary cirrhosis\n* Patient has received treatment with an investigational product within 12 weeks prior to Visit 1", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "78 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "referencesModule": {"references": [{"pmid": "23909985", "type": "RESULT", "citation": "Henry RR, Staels B, Fonseca VA, Chou MZ, Teng R, Golm GT, Langdon RB, Kaufman KD, Steinberg H, Goldstein BJ. Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone--a factorial study. Diabetes Obes Metab. 2014 Mar;16(3):223-30. doi: 10.1111/dom.12194. Epub 2013 Aug 29."}]}, "ipdSharingStatementModule": {"ipdSharing": "YES", "description": "http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf\n\nhttp://engagezone.msd.com/ds_documentation.php"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Sitagliptin 100 mg", "description": "Sitagliptin 100 mg and matching placebo to pioglitazone once daily for 54 weeks."}, {"id": "FG001", "title": "Pioglitazone 15 mg", "description": "Pioglitazone 15 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "FG002", "title": "Pioglitazone 30 mg", "description": "Pioglitazone 30 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "FG003", "title": "Pioglitazone 45 mg", "description": "Pioglitazone 45 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "FG004", "title": "Sitagliptin 100 mg/ Pioglitazone 15 mg", "description": "Sitagliptin 100 mg and pioglitazone 15 mg once daily for 54 weeks."}, {"id": "FG005", "title": "Sitagliptin 100 mg/ Pioglitazone 30 mg", "description": "Sitagliptin 100 mg and pioglitazone 30 mg once daily for 54 weeks."}, {"id": "FG006", "title": "Sitagliptin 100 mg/ Pioglitazone 45 mg", "description": "Sitagliptin 100 mg and pioglitazone 45 mg once daily for 54 weeks."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "231"}, {"groupId": "FG001", "numSubjects": "230"}, {"groupId": "FG002", "numSubjects": "233"}, {"groupId": "FG003", "numSubjects": "230"}, {"groupId": "FG004", "numSubjects": "230"}, {"groupId": "FG005", "numSubjects": "231"}, {"groupId": "FG006", "numSubjects": "230"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "175"}, {"groupId": "FG001", "numSubjects": "158"}, {"groupId": "FG002", "numSubjects": "168"}, {"groupId": "FG003", "numSubjects": "167"}, {"groupId": "FG004", "numSubjects": "182"}, {"groupId": "FG005", "numSubjects": "178"}, {"groupId": "FG006", "numSubjects": "179"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "56"}, {"groupId": "FG001", "numSubjects": "72"}, {"groupId": "FG002", "numSubjects": "65"}, {"groupId": "FG003", "numSubjects": "63"}, {"groupId": "FG004", "numSubjects": "48"}, {"groupId": "FG005", "numSubjects": "53"}, {"groupId": "FG006", "numSubjects": "51"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "13"}, {"groupId": "FG002", "numSubjects": "9"}, {"groupId": "FG003", "numSubjects": "10"}, {"groupId": "FG004", "numSubjects": "6"}, {"groupId": "FG005", "numSubjects": "8"}, {"groupId": "FG006", "numSubjects": "4"}]}, {"type": "Contraindication", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}]}, {"type": "Creatinine / Creatinine clearance", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "2"}, {"groupId": "FG003", "numSubjects": "3"}, {"groupId": "FG004", "numSubjects": "2"}, {"groupId": "FG005", "numSubjects": "1"}, {"groupId": "FG006", "numSubjects": "1"}]}, {"type": "Excluded medication", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "1"}]}, {"type": "Hyperglycemia", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "6"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "2"}, {"groupId": "FG004", "numSubjects": "5"}, {"groupId": "FG005", "numSubjects": "1"}, {"groupId": "FG006", "numSubjects": "1"}]}, {"type": "Hypoglycemia", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}]}, {"type": "Lack of Efficacy", "reasons": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "6"}, {"groupId": "FG002", "numSubjects": "6"}, {"groupId": "FG003", "numSubjects": "6"}, {"groupId": "FG004", "numSubjects": "2"}, {"groupId": "FG005", "numSubjects": "3"}, {"groupId": "FG006", "numSubjects": "0"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "11"}, {"groupId": "FG001", "numSubjects": "14"}, {"groupId": "FG002", "numSubjects": "21"}, {"groupId": "FG003", "numSubjects": "13"}, {"groupId": "FG004", "numSubjects": "8"}, {"groupId": "FG005", "numSubjects": "16"}, {"groupId": "FG006", "numSubjects": "13"}]}, {"type": "Physician Decision", "reasons": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "2"}, {"groupId": "FG003", "numSubjects": "5"}, {"groupId": "FG004", "numSubjects": "2"}, {"groupId": "FG005", "numSubjects": "3"}, {"groupId": "FG006", "numSubjects": "4"}]}, {"type": "Pregnancy", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "1"}, {"groupId": "FG006", "numSubjects": "0"}]}, {"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "4"}, {"groupId": "FG005", "numSubjects": "2"}, {"groupId": "FG006", "numSubjects": "1"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "18"}, {"groupId": "FG001", "numSubjects": "27"}, {"groupId": "FG002", "numSubjects": "19"}, {"groupId": "FG003", "numSubjects": "23"}, {"groupId": "FG004", "numSubjects": "19"}, {"groupId": "FG005", "numSubjects": "18"}, {"groupId": "FG006", "numSubjects": "26"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Sitagliptin 100 mg", "description": "Sitagliptin 100 mg and matching placebo to pioglitazone once daily for 54 weeks."}, {"id": "BG001", "title": "Pioglitazone 15 mg", "description": "Pioglitazone 15 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "BG002", "title": "Pioglitazone 30 mg", "description": "Pioglitazone 30 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "BG003", "title": "Pioglitazone 45 mg", "description": "Pioglitazone 45 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "BG004", "title": "Sitagliptin 100 mg/ Pioglitazone 15 mg", "description": "Sitagliptin 100 mg and pioglitazone 15 mg once daily for 54 weeks."}, {"id": "BG005", "title": "Sitagliptin 100 mg/ Pioglitazone 30 mg", "description": "Sitagliptin 100 mg and pioglitazone 30 mg once daily for 54 weeks."}, {"id": "BG006", "title": "Sitagliptin 100 mg/ Pioglitazone 45 mg", "description": "Sitagliptin 100 mg and pioglitazone 45 mg once daily for 54 weeks."}, {"id": "BG007", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "231"}, {"groupId": "BG001", "value": "230"}, {"groupId": "BG002", "value": "233"}, {"groupId": "BG003", "value": "230"}, {"groupId": "BG004", "value": "230"}, {"groupId": "BG005", "value": "231"}, {"groupId": "BG006", "value": "230"}, {"groupId": "BG007", "value": "1615"}]}], "measures": [{"title": "Age, Customized", "paramType": "NUMBER", "unitOfMeasure": "Participants", "classes": [{"title": "<=20 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}]}]}, {"title": "21 to 30 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "2"}, {"groupId": "BG003", "value": "5"}, {"groupId": "BG004", "value": "5"}, {"groupId": "BG005", "value": "8"}, {"groupId": "BG006", "value": "4"}, {"groupId": "BG007", "value": "35"}]}]}, {"title": "31 to 40 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "37"}, {"groupId": "BG001", "value": "39"}, {"groupId": "BG002", "value": "33"}, {"groupId": "BG003", "value": "20"}, {"groupId": "BG004", "value": "17"}, {"groupId": "BG005", "value": "34"}, {"groupId": "BG006", "value": "15"}, {"groupId": "BG007", "value": "195"}]}]}, {"title": "41 to 50 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "64"}, {"groupId": "BG001", "value": "73"}, {"groupId": "BG002", "value": "60"}, {"groupId": "BG003", "value": "70"}, {"groupId": "BG004", "value": "73"}, {"groupId": "BG005", "value": "60"}, {"groupId": "BG006", "value": "68"}, {"groupId": "BG007", "value": "468"}]}]}, {"title": "51 to 60 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "83"}, {"groupId": "BG001", "value": "67"}, {"groupId": "BG002", "value": "88"}, {"groupId": "BG003", "value": "76"}, {"groupId": "BG004", "value": "80"}, {"groupId": "BG005", "value": "75"}, {"groupId": "BG006", "value": "87"}, {"groupId": "BG007", "value": "556"}]}]}, {"title": "61 to 70 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "31"}, {"groupId": "BG001", "value": "34"}, {"groupId": "BG002", "value": "45"}, {"groupId": "BG003", "value": "53"}, {"groupId": "BG004", "value": "44"}, {"groupId": "BG005", "value": "49"}, {"groupId": "BG006", "value": "51"}, {"groupId": "BG007", "value": "307"}]}]}, {"title": ">70 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "11"}, {"groupId": "BG001", "value": "11"}, {"groupId": "BG002", "value": "5"}, {"groupId": "BG003", "value": "6"}, {"groupId": "BG004", "value": "11"}, {"groupId": "BG005", "value": "5"}, {"groupId": "BG006", "value": "5"}, {"groupId": "BG007", "value": "54"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "95"}, {"groupId": "BG001", "value": "82"}, {"groupId": "BG002", "value": "106"}, {"groupId": "BG003", "value": "117"}, {"groupId": "BG004", "value": "112"}, {"groupId": "BG005", "value": "96"}, {"groupId": "BG006", "value": "95"}, {"groupId": "BG007", "value": "703"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "136"}, {"groupId": "BG001", "value": "148"}, {"groupId": "BG002", "value": "127"}, {"groupId": "BG003", "value": "113"}, {"groupId": "BG004", "value": "118"}, {"groupId": "BG005", "value": "135"}, {"groupId": "BG006", "value": "135"}, {"groupId": "BG007", "value": "912"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Change From Baseline in Hemoglobin A1C (A1C) at Week 24", "description": "A1C represents the percentage of glycosylated hemoglobin.", "populationDescription": "Full Analysis Set with last observation carried forward (LOCF). Reasons for exclusion included no baseline data and/or no post-baseline data.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage of glycosylated hemoglobin", "timeFrame": "Baseline and Week 24", "groups": [{"id": "OG000", "title": "Sitagliptin 100 mg", "description": "Sitagliptin 100 mg and matching placebo to pioglitazone once daily for 54 weeks."}, {"id": "OG001", "title": "Pioglitazone 15 mg", "description": "Pioglitazone 15 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG002", "title": "Pioglitazone 30 mg", "description": "Pioglitazone 30 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG003", "title": "Pioglitazone 45 mg", "description": "Pioglitazone 45 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG004", "title": "Sitagliptin 100 mg/ Pioglitazone 15 mg", "description": "Sitagliptin 100 mg and pioglitazone 15 mg once daily for 54 weeks."}, {"id": "OG005", "title": "Sitagliptin 100 mg/ Pioglitazone 30 mg", "description": "Sitagliptin 100 mg and pioglitazone 30 mg once daily for 54 weeks."}, {"id": "OG006", "title": "Sitagliptin 100 mg/ Pioglitazone 45 mg", "description": "Sitagliptin 100 mg and pioglitazone 45 mg once daily for 54 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "172"}, {"groupId": "OG001", "value": "163"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "171"}, {"groupId": "OG004", "value": "179"}, {"groupId": "OG005", "value": "173"}, {"groupId": "OG006", "value": "188"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-1.09", "lowerLimit": "-1.29", "upperLimit": "-0.89"}, {"groupId": "OG001", "value": "-0.88", "lowerLimit": "-1.09", "upperLimit": "-0.68"}, {"groupId": "OG002", "value": "-1.21", "lowerLimit": "-1.41", "upperLimit": "-1.02"}, {"groupId": "OG003", "value": "-1.20", "lowerLimit": "-1.40", "upperLimit": "-1.00"}, {"groupId": "OG004", "value": "-1.53", "lowerLimit": "-1.73", "upperLimit": "-1.34"}, {"groupId": "OG005", "value": "-1.63", "lowerLimit": "-1.82", "upperLimit": "-1.43"}, {"groupId": "OG006", "value": "-1.81", "lowerLimit": "-2.00", "upperLimit": "-1.62"}]}]}]}, {"type": "SECONDARY", "title": "Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24", "populationDescription": "Full Analysis Set with LOCF. Reasons for exclusion included no baseline data and/or no post-baseline data.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline and Week 24", "groups": [{"id": "OG000", "title": "Sitagliptin 100 mg", "description": "Sitagliptin 100 mg and matching placebo to pioglitazone once daily for 54 weeks."}, {"id": "OG001", "title": "Pioglitazone 15 mg", "description": "Pioglitazone 15 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG002", "title": "Pioglitazone 30 mg", "description": "Pioglitazone 30 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG003", "title": "Pioglitazone 45 mg", "description": "Pioglitazone 45 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG004", "title": "Sitagliptin 100 mg/ Pioglitazone 15 mg", "description": "Sitagliptin 100 mg and pioglitazone 15 mg once daily for 54 weeks."}, {"id": "OG005", "title": "Sitagliptin 100 mg/ Pioglitazone 30 mg", "description": "Sitagliptin 100 mg and pioglitazone 30 mg once daily for 54 weeks."}, {"id": "OG006", "title": "Sitagliptin 100 mg/ Pioglitazone 45 mg", "description": "Sitagliptin 100 mg and pioglitazone 45 mg once daily for 54 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "179"}, {"groupId": "OG001", "value": "176"}, {"groupId": "OG002", "value": "185"}, {"groupId": "OG003", "value": "181"}, {"groupId": "OG004", "value": "189"}, {"groupId": "OG005", "value": "181"}, {"groupId": "OG006", "value": "193"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-24.3", "lowerLimit": "-32.0", "upperLimit": "-16.5"}, {"groupId": "OG001", "value": "-19.5", "lowerLimit": "-27.2", "upperLimit": "-11.7"}, {"groupId": "OG002", "value": "-29.9", "lowerLimit": "-37.6", "upperLimit": "-22.3"}, {"groupId": "OG003", "value": "-37.4", "lowerLimit": "-45.1", "upperLimit": "-29.7"}, {"groupId": "OG004", "value": "-41.0", "lowerLimit": "-48.5", "upperLimit": "-33.5"}, {"groupId": "OG005", "value": "-46.9", "lowerLimit": "-54.6", "upperLimit": "-39.3"}, {"groupId": "OG006", "value": "-52.0", "lowerLimit": "-59.6", "upperLimit": "-44.5"}]}]}]}, {"type": "SECONDARY", "title": "Change From Baseline in 2-Hour Post-meal Glucose (PMG) at Week 24", "description": "PMG was measured using the Meal Tolerance Test (MTT).", "populationDescription": "Full Analysis Set with LOCF. Reasons for exclusion included no baseline data and/or no post-baseline data.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline and Week 24", "groups": [{"id": "OG000", "title": "Sitagliptin 100 mg", "description": "Sitagliptin 100 mg and matching placebo to pioglitazone once daily for 54 weeks."}, {"id": "OG001", "title": "Pioglitazone 15 mg", "description": "Pioglitazone 15 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG002", "title": "Pioglitazone 30 mg", "description": "Pioglitazone 30 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG003", "title": "Pioglitazone 45 mg", "description": "Pioglitazone 45 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG004", "title": "Sitagliptin 100 mg/ Pioglitazone 15 mg", "description": "Sitagliptin 100 mg and pioglitazone 15 mg once daily for 54 weeks."}, {"id": "OG005", "title": "Sitagliptin 100 mg/ Pioglitazone 30 mg", "description": "Sitagliptin 100 mg and pioglitazone 30 mg once daily for 54 weeks."}, {"id": "OG006", "title": "Sitagliptin 100 mg/ Pioglitazone 45 mg", "description": "Sitagliptin 100 mg and pioglitazone 45 mg once daily for 54 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "141"}, {"groupId": "OG001", "value": "128"}, {"groupId": "OG002", "value": "158"}, {"groupId": "OG003", "value": "136"}, {"groupId": "OG004", "value": "149"}, {"groupId": "OG005", "value": "143"}, {"groupId": "OG006", "value": "154"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-51.1", "lowerLimit": "-64.0", "upperLimit": "-38.2"}, {"groupId": "OG001", "value": "-30.6", "lowerLimit": "-44.0", "upperLimit": "-17.3"}, {"groupId": "OG002", "value": "-52.5", "lowerLimit": "-64.9", "upperLimit": "-40.2"}, {"groupId": "OG003", "value": "-66.6", "lowerLimit": "-79.8", "upperLimit": "-53.5"}, {"groupId": "OG004", "value": "-69.2", "lowerLimit": "-81.7", "upperLimit": "-56.7"}, {"groupId": "OG005", "value": "-85.5", "lowerLimit": "-98.4", "upperLimit": "-72.6"}, {"groupId": "OG006", "value": "-93.8", "lowerLimit": "-106.4", "upperLimit": "-81.2"}]}]}]}, {"type": "PRIMARY", "title": "Change From Baseline in A1C at Week 54", "description": "A1C represents the percentage of glycosylated hemoglobin.", "populationDescription": "Full Analysis Set with LOCF. Reasons for exclusion included no baseline data and/or no post-baseline data.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percent of glycosylated hemoglobin", "timeFrame": "Baseline and Week 54", "groups": [{"id": "OG000", "title": "Sitagliptin 100 mg", "description": "Sitagliptin 100 mg and matching placebo to pioglitazone once daily for 54 weeks."}, {"id": "OG001", "title": "Pioglitazone 15 mg", "description": "Pioglitazone 15 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG002", "title": "Pioglitazone 30 mg", "description": "Pioglitazone 30 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG003", "title": "Pioglitazone 45 mg", "description": "Pioglitazone 45 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG004", "title": "Sitagliptin 100 mg/ Pioglitazone 15 mg", "description": "Sitagliptin 100 mg and pioglitazone 15 mg once daily for 54 weeks."}, {"id": "OG005", "title": "Sitagliptin 100 mg/ Pioglitazone 30 mg", "description": "Sitagliptin 100 mg and pioglitazone 30 mg once daily for 54 weeks."}, {"id": "OG006", "title": "Sitagliptin 100 mg/ Pioglitazone 45 mg", "description": "Sitagliptin 100 mg and pioglitazone 45 mg once daily for 54 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "172"}, {"groupId": "OG001", "value": "163"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "171"}, {"groupId": "OG004", "value": "179"}, {"groupId": "OG005", "value": "173"}, {"groupId": "OG006", "value": "188"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.93", "lowerLimit": "-1.15", "upperLimit": "-0.72"}, {"groupId": "OG001", "value": "-0.74", "lowerLimit": "-0.96", "upperLimit": "-0.53"}, {"groupId": "OG002", "value": "-1.16", "lowerLimit": "-1.37", "upperLimit": "-0.95"}, {"groupId": "OG003", "value": "-1.23", "lowerLimit": "-1.45", "upperLimit": "-1.02"}, {"groupId": "OG004", "value": "-1.45", "lowerLimit": "-1.65", "upperLimit": "-1.24"}, {"groupId": "OG005", "value": "-1.49", "lowerLimit": "-1.71", "upperLimit": "-1.28"}, {"groupId": "OG006", "value": "-1.78", "lowerLimit": "-1.99", "upperLimit": "-1.58"}]}]}]}, {"type": "SECONDARY", "title": "Change From Baseline in FPG at Week 54", "populationDescription": "Full Analysis Set with LOCF. Reasons for exclusion included no baseline data and/or no post-baseline data.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline and Week 54", "groups": [{"id": "OG000", "title": "Sitagliptin 100 mg", "description": "Sitagliptin 100 mg and matching placebo to pioglitazone once daily for 54 weeks."}, {"id": "OG001", "title": "Pioglitazone 15 mg", "description": "Pioglitazone 15 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG002", "title": "Pioglitazone 30 mg", "description": "Pioglitazone 30 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG003", "title": "Pioglitazone 45 mg", "description": "Pioglitazone 45 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG004", "title": "Sitagliptin 100 mg/ Pioglitazone 15 mg", "description": "Sitagliptin 100 mg and pioglitazone 15 mg once daily for 54 weeks."}, {"id": "OG005", "title": "Sitagliptin 100 mg/ Pioglitazone 30 mg", "description": "Sitagliptin 100 mg and pioglitazone 30 mg once daily for 54 weeks."}, {"id": "OG006", "title": "Sitagliptin 100 mg/ Pioglitazone 45 mg", "description": "Sitagliptin 100 mg and pioglitazone 45 mg once daily for 54 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "179"}, {"groupId": "OG001", "value": "176"}, {"groupId": "OG002", "value": "185"}, {"groupId": "OG003", "value": "181"}, {"groupId": "OG004", "value": "189"}, {"groupId": "OG005", "value": "181"}, {"groupId": "OG006", "value": "193"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-13.1", "lowerLimit": "-21.6", "upperLimit": "-4.5"}, {"groupId": "OG001", "value": "-10.5", "lowerLimit": "-19.0", "upperLimit": "-2.0"}, {"groupId": "OG002", "value": "-24.0", "lowerLimit": "-32.4", "upperLimit": "-15.5"}, {"groupId": "OG003", "value": "-33.3", "lowerLimit": "-41.8", "upperLimit": "-24.8"}, {"groupId": "OG004", "value": "-33.9", "lowerLimit": "-42.2", "upperLimit": "-25.7"}, {"groupId": "OG005", "value": "-37.1", "lowerLimit": "-45.5", "upperLimit": "-28.6"}, {"groupId": "OG006", "value": "-47.8", "lowerLimit": "-56.1", "upperLimit": "-39.5"}]}]}]}, {"type": "SECONDARY", "title": "Change From Baseline in 2-Hour PMG at Week 54", "description": "PMG was measured using the Meal Tolerance Test (MTT).", "populationDescription": "Full Analysis Set with LOCF. Reasons for exclusion included no baseline data and/or no post-baseline data.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline and Week 54", "groups": [{"id": "OG000", "title": "Sitagliptin 100 mg", "description": "Sitagliptin 100 mg and matching placebo to pioglitazone once daily for 54 weeks."}, {"id": "OG001", "title": "Pioglitazone 15 mg", "description": "Pioglitazone 15 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG002", "title": "Pioglitazone 30 mg", "description": "Pioglitazone 30 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG003", "title": "Pioglitazone 45 mg", "description": "Pioglitazone 45 mg and matching placebo to sitagliptin once daily for 54 weeks."}, {"id": "OG004", "title": "Sitagliptin 100 mg/ Pioglitazone 15 mg", "description": "Sitagliptin 100 mg and pioglitazone 15 mg once daily for 54 weeks."}, {"id": "OG005", "title": "Sitagliptin 100 mg/ Pioglitazone 30 mg", "description": "Sitagliptin 100 mg and pioglitazone 30 mg once daily for 54 weeks."}, {"id": "OG006", "title": "Sitagliptin 100 mg/ Pioglitazone 45 mg", "description": "Sitagliptin 100 mg and pioglitazone 45 mg once daily for 54 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "145"}, {"groupId": "OG001", "value": "131"}, {"groupId": "OG002", "value": "158"}, {"groupId": "OG003", "value": "141"}, {"groupId": "OG004", "value": "150"}, {"groupId": "OG005", "value": "143"}, {"groupId": "OG006", "value": "157"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-37.0", "lowerLimit": "-50.2", "upperLimit": "-23.7"}, {"groupId": "OG001", "value": "-26.7", "lowerLimit": "-40.5", "upperLimit": "-13.0"}, {"groupId": "OG002", "value": "-46.8", "lowerLimit": "-59.6", "upperLimit": "-34.1"}, {"groupId": "OG003", "value": "-58.2", "lowerLimit": "-71.6", "upperLimit": "-44.7"}, {"groupId": "OG004", "value": "-64.7", "lowerLimit": "-77.6", "upperLimit": "-51.8"}, {"groupId": "OG005", "value": "-69.7", "lowerLimit": "-83.1", "upperLimit": "-56.4"}, {"groupId": "OG006", "value": "-88.2", "lowerLimit": "-101.2", "upperLimit": "-75.3"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "eventGroups": [{"id": "EG000", "title": "Sitagliptin 100 mg", "description": "Sitagliptin 100 mg and matching placebo to pioglitazone once daily for 54 weeks.", "seriousNumAffected": 14, "seriousNumAtRisk": 231, "otherNumAffected": 60, "otherNumAtRisk": 231}, {"id": "EG001", "title": "Pioglitazone 15 mg", "description": "Pioglitazone 15 mg and matching placebo to sitagliptin once daily for 54 weeks.", "seriousNumAffected": 10, "seriousNumAtRisk": 230, "otherNumAffected": 41, "otherNumAtRisk": 230}, {"id": "EG002", "title": "Pioglitazone 30 mg", "description": "Pioglitazone 30 mg and matching placebo to sitagliptin once daily for 54 weeks.", "seriousNumAffected": 5, "seriousNumAtRisk": 233, "otherNumAffected": 45, "otherNumAtRisk": 233}, {"id": "EG003", "title": "Pioglitazone 45 mg", "description": "Pioglitazone 45 mg and matching placebo to sitagliptin once daily for 54 weeks.", "seriousNumAffected": 11, "seriousNumAtRisk": 230, "otherNumAffected": 55, "otherNumAtRisk": 230}, {"id": "EG004", "title": "Sitagliptin 100 mg/ Pioglitazone 15 mg", "description": "Sitagliptin 100 mg and pioglitazone 15 mg once daily for 54 weeks.", "seriousNumAffected": 12, "seriousNumAtRisk": 230, "otherNumAffected": 48, "otherNumAtRisk": 230}, {"id": "EG005", "title": "Sitagliptin 100 mg/ Pioglitazone 30 mg", "description": "Sitagliptin 100 mg and pioglitazone 30 mg once daily for 54 weeks.", "seriousNumAffected": 15, "seriousNumAtRisk": 231, "otherNumAffected": 56, "otherNumAtRisk": 231}, {"id": "EG006", "title": "Sitagliptin 100 mg/ Pioglitazone 45 mg", "description": "Sitagliptin 100 mg and pioglitazone 45 mg once daily for 54 weeks.", "seriousNumAffected": 7, "seriousNumAtRisk": 230, "otherNumAffected": 46, "otherNumAtRisk": 230}], "seriousEvents": [{"term": "Angina unstable", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 2, "numAffected": 2, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Atrial flutter", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Cardiac failure congestive", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}]}, {"term": "Coronary artery disease", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Mitral valve disease", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}]}, {"term": "Myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 2, "numAffected": 2, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Myocardial ischaemia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Supraventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Optic ischaemic neuropathy", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Anal fissure", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}]}, {"term": "Gastrooesophageal reflux disease", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Pancreatitis acute", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Varices oesophageal", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Non-cardiac chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}]}, {"term": "Cholelithiasis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Drug hypersensitivity", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Hypersensitivity", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Appendicitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Bronchopneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Dengue fever", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Endocarditis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}]}, {"term": "Escherichia urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Gastroenteritis viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Lobar pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Tuberculosis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Wound infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Foot fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Multiple injuries", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Splenic haematoma", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Tendon rupture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Upper limb fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Alanine aminotransferase increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 2, "numAffected": 1, "numAtRisk": 230}]}, {"term": "Aspartate aminotransferase increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}]}, {"term": "Decreased appetite", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Type 1 diabetes mellitus", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Back pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Bursitis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Intervertebral disc protrusion", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Osteoarthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}]}, {"term": "Basal cell carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Bladder cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Breast cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Malignant melanoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Myelodysplastic syndrome", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Pancreatic carcinoma metastatic", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Prostate cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}]}, {"term": "Prostate cancer stage III", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Squamous cell carcinoma of skin", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Cerebral infarction", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Cerebral ischaemia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Cerebrovascular accident", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Complicated migraine", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Convulsion", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Epilepsy", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Haemorrhage intracranial", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Sciatica", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}]}, {"term": "Anxiety", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 2, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Chronic obstructive pulmonary disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}]}, {"term": "Pulmonary embolism", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Arteriosclerosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Deep vein thrombosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}, {"term": "Hypertensive emergency", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}], "otherEvents": [{"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 13, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 11, "numAffected": 10, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 16, "numAffected": 12, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 10, "numAffected": 9, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 15, "numAffected": 12, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 19, "numAffected": 15, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 10, "numAffected": 8, "numAtRisk": 230}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 10, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 9, "numAffected": 8, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 12, "numAffected": 12, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 13, "numAffected": 11, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 11, "numAffected": 9, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 13, "numAffected": 11, "numAtRisk": 230}]}, {"term": "Hypoglycaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 57, "numAffected": 25, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 30, "numAffected": 20, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 78, "numAffected": 22, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 81, "numAffected": 20, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 45, "numAffected": 20, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 100, "numAffected": 26, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 93, "numAffected": 24, "numAtRisk": 230}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 18, "numAffected": 17, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 8, "numAffected": 6, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 9, "numAffected": 9, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 12, "numAffected": 11, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 8, "numAffected": 8, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 18, "numAffected": 14, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 5, "numAffected": 5, "numAtRisk": 230}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 13.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 7, "numAtRisk": 231}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 230}, {"groupId": "EG002", "numEvents": 4, "numAffected": 4, "numAtRisk": 233}, {"groupId": "EG003", "numEvents": 11, "numAffected": 10, "numAtRisk": 230}, {"groupId": "EG004", "numEvents": 13, "numAffected": 13, "numAtRisk": 230}, {"groupId": "EG005", "numEvents": 9, "numAffected": 6, "numAtRisk": 231}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 230}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation."}, "pointOfContact": {"title": "Senior Vice President, Global Clinical Development", "organization": "Merck Sharp & Dohme Corp", "email": "ClinicalTrialsDisclosure@merck.com", "phone": "1-800-672-6372"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "removedCountries": ["Australia", "Austria", "Brazil", "Bulgaria", "Chile", "Colombia", "Costa Rica", "Croatia", "Ecuador", "Egypt", "Estonia", "Greece", "India", "Italy", "Latvia", "Lebanon", "Lithuania", "Mexico", "Peru", "Philippines", "Russian Federation", "Saudi Arabia", "Serbia", "Slovenia", "South Africa", "Taiwan", "Turkey", "United States"]}, "conditionBrowseModule": {"meshes": [{"id": "D000003920", "term": "Diabetes Mellitus"}, {"id": "D000003924", "term": "Diabetes Mellitus, Type 2"}], "ancestors": [{"id": "D000044882", "term": "Glucose Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}, {"id": "D000004700", "term": "Endocrine System Diseases"}], "browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "asFound": "Diabetes Mellitus", "relevance": "HIGH"}, {"id": "M7119", "name": "Diabetes Mellitus, Type 2", "asFound": "Type 2 Diabetes Mellitus", "relevance": "HIGH"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M25403", "name": "Glucose Metabolism Disorders", "relevance": "LOW"}, {"id": "M7862", "name": "Endocrine System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000008687", "term": "Metformin"}, {"id": "D000077205", "term": "Pioglitazone"}, {"id": "D000068900", "term": "Sitagliptin Phosphate"}], "ancestors": [{"id": "D000007004", "term": "Hypoglycemic Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000054795", "term": "Incretins"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000054873", "term": "Dipeptidyl-Peptidase IV Inhibitors"}, {"id": "D000011480", "term": "Protease Inhibitors"}, {"id": "D000004791", "term": "Enzyme Inhibitors"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M11667", "name": "Metformin", "asFound": "Assessment", "relevance": "HIGH"}, {"id": "M1693", "name": "Pioglitazone", "asFound": "Registry", "relevance": "HIGH"}, {"id": "M335", "name": "Sitagliptin Phosphate", "asFound": "Percutaneous", "relevance": "HIGH"}, {"id": "M10054", "name": "Hypoglycemic Agents", "relevance": "LOW"}, {"id": "M27905", "name": "Incretins", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M27957", "name": "Dipeptidyl-Peptidase IV Inhibitors", "relevance": "LOW"}, {"id": "M19609", "name": "HIV Protease Inhibitors", "relevance": "LOW"}, {"id": "M14343", "name": "Protease Inhibitors", "relevance": "LOW"}, {"id": "M7951", "name": "Enzyme Inhibitors", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Hypo", "name": "Hypoglycemic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "Infe", "name": "Anti-Infective Agents"}]}}, "hasResults": true}